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~,bstract Lipopolysaccharides (LPS, endotoxin) stimulate 
mononuclear cells to release cytokines which initiate endotoxic 
effects. Interaction of LPS at low concentrations with target 
cells is CDl4-dependent whereas at high LPS concentrations it is 
CD14-independent. Here, we demonstrate by resonance nergy 
transfer (RET) technique that nonspecific, CDl4-independent 
intercalation of LPS into membrane systems can be mediated by 
lipopolysaccharide-binding protein (LBP). It is proposed that in 
this pathway, LBP breaks down LPS aggregates, transports the 
smaller units to and inserts them into the phospholipid cell 
matrix. We furthermore show that LBP also mediates the 
intercalation of other negatively charged amphiphilic molecules. 
We propose a model explaining CD14-independent cell activa- 
tion at high endotoxin concentrations. 
Key words: LBP; Endotoxin; Bactericidal/permeability- 
increasing protein; Nonspecific intercalation; Phospholipid 
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1. Introduction 
Lipopolysaccharide (LPS, endotoxin) constitutes the major 
surface component of the outer membrane of Gram-negative 
bacteria. In mammals, LPS induces a variety of biological 
effects which, if left untreated, culminate in manifestations 
of septic shock (fever, tachypnoe, tachycardia, hypotension, 
and multi-organ failure). The initiation of these effects is due 
to an activation of monocytes/macrophages, leading to the 
secretion of proinflammatory c tokines uch as TNF-a, IL- 
113, IL-6, and IL-8 [1,2]. Several types of interactions between 
endotoxin and host cells have been observed. Thus, the bind- 
ing of LPS to a specific cellular receptor molecule, the phos- 
phatidylinositol-anchored protein mCD14, has been described 
as a critical event in the activation of cells [3-6]. In the case of 
CD14-negative endothelial and epithelial cells a soluble form 
of CD14 (sCD14) mediates LPS binding [7]. The binding of 
LPS to CD14 is facilitated by LPS-binding protein (LBP) 
[8,9]. According to present knowledge, LBP associates with 
LPS and the LPS/LBP complex is then thought to interact 
with CD14 [3,10-12]. 
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In addition to these receptor-mediated processes, several 
observations indicate that a CD14-independent direct activa- 
tion of cells may be operative, particularly at higher endotoxin 
concentrations (0.1-10 ~tg/ml). Such concentrations have been 
measured in human meningococcal sepsis [13]. In in vitro 
experiments it has been shown that CD14-negative cells are 
reactive to high doses of LPS and the inhibition of CD14- 
dependent cell activation by anti-CD14 antibodies may be 
overcome by higher endotoxin doses [4,14,15]. The molecular 
mechanisms of CD14-independent cell activation have not yet 
been elucidated. Also, at saturating LPS concentrations, the 
molar ratio of LPS bound to CD14 is considerably higher 
than one [16], suggesting the existence of other cell activation 
mechanisms. Thus, a CD14-independent activation mecha- 
nism which is based on nonspecific hydrophobic intercalation 
of endotoxin molecules into the phospholipid matrix of the 
host cell membrane would be in accordance with these obser- 
vations. It has been postulated that the activation of host cells 
is based on the association of LPS with the target cell, result- 
ing in an interdigitation of the lipid A acyl residues into the 
cell membrane [17]. Subsequent experiments have provided 
supportive vidence for a receptor-independent intercalation 
of LPS [18-21]. However, we recently showed that in the 
absence of transport proteins nonspecific intercalation of en- 
dotoxin aggregates into PL membranes driven only by hydro- 
phobic interactions does not take place in the time scale of cell 
activation [22]. 
Endotoxins are amphiphilic molecules and, therefore, tend 
to form multimeric lusters in an aqueous environment above 
a critical aggregate concentration (CAC). The absolute values 
of CAC for endotoxin of various chemical structures will 
likely depend on the acylation pattern and the length of the 
sugar moiety. Therefore, they should be lowest for free lipid A 
and deep rough mutant LPS but have not yet been deter- 
mined. From a comparison with the published value for di- 
palmitoylphosphatidylcholine [23], the CAC of LPS should be 
in the order of 10 -l° M or below. Under normal experimental 
in vitro conditions, endotoxins hould therefore form aggre- 
gates. There is, however, evidence that endotoxin monomers 
are biologically more active than aggregates [24]. There is also 
evidence that LBP has a critical function in the activation of 
cells at low endotoxin concentrations by breaking down the 
size of LPS aggregates, by binding endotoxin in a 1:1 stoi- 
chiometry and by presenting endotoxin monomers to the host 
cell recognition structures as well as to other endotoxin bind- 
ing proteins such as soluble CD14 and high-density lipopro- 
teins [10,12]. In this way, LBP would act as a disaggregating 
protein and would guide LPS to several targets. 
We have investigated the role of LBP and other proteins 
0014-5793/96/$12.00 ¢) 1996 Federation of European Biochemical Societies. All rights reserved. 
PII SO0 l 4 -5793(96)0  13 3 8-5 
268 A.B. Schromm et al./FEBS Letters 399 (1996) 267-271 
which are known to bind LPS such as bovine serum albumin 
(BSA), lysozyme, the complement component C lq,  and the 
bactericidal/permeability-increasing protein (BPI) in the inter- 
action of endotoxin aggregates with the lipid matrix of target 
cell membranes. Membranes were constructed as protein-free 
phospholipid liposomes resembling the composition of the 
macrophage membrane (PLMo). Resonance energy transfer 
(RET) was applied as a sensitive technique to detect he inter- 
calation of endotoxin molecules into the liposomal membrane. 
2. Materials and methods 
2.1. Preparation of lipopolysaccharides and phospholipids 
Rough muant LPS was extracted according to the phenol-chloro- 
form-petroleum ether method [25] from Salmonella enterica serovar 
Minnesota strains R595 (Re), R5 (Rc), and R60 (Ra). LPS prepara- 
tions were used in their natural salt form. Free lipid A was obtained 
by acetate buffer treatment (1 M, 100°C, 1.5 h) of Re LPS and sub- 
sequent dialysis and conversion to the triethylammonium salt form. 
For preparation of dephosphorylated LPS (P LPS), Re LPS isolated 
from Escherichia coli strain F515 was treated with hydrofluoric acid 
(48%, 4°C, 72 h). After purification the phosphate content was deter- 
mined to be lower than 5%. For intercalation experiments, free lipid A 
and LPS were prepared as 1 mM aqueous dispersions in phosphate- 
buffered saline (PBS) at pH 7.2, mixed thoroughly, and sonicated with 
a Branson sonifier for 1 min (1 ml solution). Subsequently, the prep- 
arations were cooled for 30 min at 4°C, heated for 30 min at 56°C, 
and recooled to 4°C. Preparations were stored at 4°C overnight prior 
to experiments. 
Bovine brain L-a-phosphatidyl-L-serine, egg L-c~-phosphatidylchol- 
ine, and sphingomyelin from bovine brain were obtained from Sigma 
(Deisenhofen, Germany). L-c~-phosphatidylethanolamine (PE) from 
E. coli was from Avanti Polar Lipids, Inc. (Birmingham, AL). For 
preparation of liposomes from a single phospholipid or from a phos- 
pholipid mixture resembling the composition of the cell membrane of 
macrophages (PLM.) -- phosphatidylcholine, phosphatidylserine, PE
and sphingomyelin a molar ratio of 1:0.4:0.7:0.5 [26] --  the lipids 
were solubilized in chloroform, the solvent was evaporated under a 
stream of nitrogen, lipids resuspended in the appropriate volume of 
PBS and further treated as described for LPS. 
2.2. Proteins 
Recombinant human LBP (456 amino acid holoprotein rLBP~0) in 
10 mM HEPES, pH 7.5, and recombinant human BPI (199 amino 
acid N-terminal fragment rBPI23) in 20 mM sodium citrate, pH 5.0, 
have been described [27,28]. BSA, chicken egg white lysozyme, and 
human complement component Clq were purchased from Sigma and 
dissolved in PBS. 
2.3. Fluorescence measurements 
For the RET assay, phospholipid liposomes were double-labeled 
with the fluorescent dyes N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-PE 
(NBD-PE) and N-(rhodamine B sulfonyl)-PE (Rh-PE), which were 
purchased from Molecular Probes (Eugene, OR). NBD-PE and Rh- 
PE were dissolved in chloroform and added to the lipids in the chloro- 
form phase to a final molar ratio [PL]/[NBD-PE]/[Rh-PE] = 100:1:1. 
The emission wavelength of one dye, the donor (NBD-PE), is in the 
range of the excitation wavelength of the second dye, the acceptor 
(Rh-PE). The energy transfer between these two dyes is sensitive to 
spatial separation. Intercalation of unlabeled molecules into the dou- 
ble-labeled liposomes leads to probe dilution and with that to a de- 
crease in the efficiency of RET: the emission intensity of the donor 
increases and that of the acceptor decreases (for the sake of clearity, 
in the figures only the donor emission intensity is shown). A prepara- 
tion of 900 ~tl of the double-labeled PL liposomes (0.1 mM) at 37°C 
was excited at 470 nm (excitation wavelength of NBD-PE), and the 
fluorescence missions of NBD-PE (531 nm) and Rh-PE (593 nm) 
were adjusted to yield identical intensities and recorded for 50 s under 
continuous tirring to determine the base line. After 50 s, unlabeled 
LPS or PL preparation (100 p.1, 1 raM) was added, respectively. After 
100 s, the appropriate amount of protein was added, and the emission 
signals were usually recorded for another 300 s. These relatively high 
concentration were chosen to obtain an optimal signal-to-noise ratio. 
In control experiments we verified that also at 2-3 orders of magni- 
tude lower concentrations of each of the two lipids detectable changes 
in the fluorescence intensities were obtained, however, the signals were 
relatively noisy. We, therefore, decided to perform the experiments at
the higher concentrations. 
3. Results 
Upon addition of proteins to an equimolar mixture of 
PLM~-liposomes and aggregates prepared from deep rough 
mutant LPS of Salmonella enterica serovar Minnesota strain 
R595 (Re LPS), the donor emission intensity rises for LBP 
and BPI, indicating incorporation of LPS into the liposomal 
membrane (Fig. 1). In contrast, BSA, lysozyme, or C lq  did 
not mediate incorporation but rather induced a slight decrease 
in emission intensity which is due to the dilution of the labeled 
liposomes by the aqueous protein solution. The kinetics of the 
increase in emission intensity exhibits a biphasic behavior with 
a very rapid first phase of a few seconds followed by a rather 
slow phase continuing even beyond the observation period. 
To further characterize the transport activity of LBP, we 
performed experiments on the concentration dependence and 
substrate specificity. The effect of LBP was concentration-de- 
pendent and detectable above a threshold concentration of 10 
~tg/ml (data not shown), which is in the range of the physio- 
logical concentration i normal human serum [8]. The effect is 
also dependent on the molar ratio of the LPS/PL~,~ mixture, 
being more pronounced for higher molar ratios (Fig. 2). From 
these experiments the transport stoichiometry between LBP 
and LPS could be assessed. Calibration measurements with 
liposomes made from constant amounts of PLM,~ and differ- 
ent amounts of LPS, which were labeled with the dyes in a 
constant molar ratio PLfNBD-PE/Rh-PE (100:1:1 M), 
showed that the lower detection limit for intercalated endo- 
toxin is around 1 mole% (corresponding to an increase in 
donor emission intensity of 8%) and that the intensity in- 
creases with the amount of intercalated endotoxin (data not 
shown). This calibration allowed the conclusion that for a 
mixture of PLMo liposomes and LPS aggregates in a 1 : 1 mo- 
lar ratio the addition of 50 ~tg LBP leads to an intercalation of 
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Fig. 1. Time kinetics of changes in donor emission intensity in RET 
experiments upon addition of various proteins (50 ~tg/ml) to 1 ml of 
equimolar mixtures (0.1 mM) of double-labeled liposomes composed 
of a phospholipid mixture (PLM~,) resembling the lipid matrix of 
mononuclear cells and aggregates prepared from Re LPS of Salmo- 
nella enterica serovar Minnesota strain R595. 
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F g. 2. Time kinetics of changes in donor emission intensity in RET 
e,periments upon addition of Re LPS suspensions (100 gl) with in- 
c~ easing concentrations to mixtures of 0.9 ml of 0.1 mM double-la- 
b,:led liposomes from PLM. and rLBPs0 (50 gl, 1 mg/ml). The final 
nolar ratio of LPS aggregates and PLM. liposomes ranged from 
0 1:1 to 10:1. 
a)out 10 mole% LPS. From the concentration of LBP (50 ktg 
i~ 1 ml) and the amount of LPS molecules transported, the 
n~olar atio between LBP and transported LPS molecules was 
determined to be 1:10. For lipid mixtures with a molar ratio 
c f  [LPS]/[PLM.] higher than 1:1, the amount of LPS trans- 
Forted by LBP was even higher. Thus, one LBP molecule 
t ansported several molecules of LPS to the lipid surface, in 
a manner similar as has been described for LBP-mediated 
transport processes with high-density lipoprotein or soluble 
(D14 as targets [10,12]. Surprisingly, the transport activitiy 
( f  LBP is not restricted to endotoxin, but was also observed 
v ith dephosphorylated Re LPS carrying two negative charges 
(n the 2-keto-3-deoxyoctonate units and negatively charged 
[,hospholipids like phosphatidylserine, -glycerol, and -inositol, 
l-ut not zwitterionic (neutral) phospholipids like phosphatidyl- 
choline and -ethanolamine. For the sake of clarity, only some 
( f the data are shown exemplarily in Fig. 3A. LPS and phos- 
t-,holipid intercalation was strongly dependent on the compo- 
sition of the phospholipid liposomes and was restricted to 
i~egatively charged liposomes as targets (Fig. 3B). Thus, 
1BP requires negative charges both for the donor lipid (phos- 
l'holipid, LPS) and on the acceptor side (membrane). For 
tiifferent LPS chemotypes, the transport activity of LBP var- 
i;:d, being highest for free lipid A and Re LPS and decreasing 
with the length of the core oligosaccharide over Rc to Ra 
lmtant LPS (Fig. 4). This phenomenon may be related to 
tile disaggregating capacity of LBP, which is less effective 
for those endotoxins having a higher CAC and consequently 
zn a-priori higher monomer concentration (higher water sol- 
~,bility). Note that, in our system, soluble CD14 (a generous 
ift of Dr. Chr. Schtitt, University of Greifswald, Germany) 
l,ad no effect on the transport of endotoxin in the presence or 
~ bsence of LBP (data not shown). 
To further elucidate the role of BPI in comparison to that 
,,f LBP, we have performed experiments in which identical 
mass amounts of rLBP50 (the 456 amino acid holoprotein) 
:nd rBPI23 (the 199 amino acid N-terminal BPI fragment) 
were added in separate xperiments o liposomes of different 
phospholipid composition in the absence of LPS (Fig. 5). 
Apparently, both proteins intercalate into negatively charged 
(but not into uncharged) liposomal membranes. However, this 
effect is much less pronounced for LBP (Fig. 5B) and might 
be explained by a lower hydrophobicity of LBP. Fig. 5A 
shows that BPI, in contrast o LBP, leads to intensity fluctua- 
tions starting about 200 s after BPI addition which is most 
likely be due to BPI-induced aggregation and precipitation of 
phospatidylserine liposomes (a similar effect has been ob- 
served at high molar excess of Ca 2+, data not shown). 
4. Discussion 
Our data show that LBP acts as an effective carrier of LPS 
and other negatively charged amphiphiles such as phosphatid- 
ylserine and dephosphorylated Re LPS, and that one LBP 
molecule transports more than one LPS molecule. It has 
been reported that the stoichiometry of binding of endotoxin 
to LBP is 1:1 [12]. From these facts it is concluded that LBP 
breaks down the lipid aggregates to smaller units, transports 
these to, and intercalates them into phospholipid target mem- 
branes. This intercalation takes place within a physiologically 
relevant ime scale. 
The observed transport capability of BPI for LPS may be 
unexpected in view of the fact that BPI reduces rather than 
increases LPS bioactivity. This apparent contrast may be ex- 
plained by intercalation of BPI/LPS assemblies in which LPS 
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Fig. 3. Time kinetics of changes in donor emission intensity in RET 
experiments upon addition of 50 gg/ml of rLBP50 to l ml of equi- 
molar mixtures (0.1 mM) of (A) PLM~ liposomes and aggregates 
prepared from Re LPS, dephosphorylated Re LPS (P- LPS), phos- 
phatidylserine (PS), and phosphatidylcholine (PC), respectively, and 
of (B) aggregates prepared from Re LPS and double-labeled lipo- 
somes composed of the negatively charged PS, the zwitterionic PC, 
and PLM~, respectively. 
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activity is neutralized, thus not contributing to cell activation. 
The obvious membrane activity of BPI, i.e., its intercalation 
into negatively charged phospholipid membranes, may be sur- 
prising, but would be in accordance with the observation of 
surface bound BPI on mononuclear cells [29]. 
The LBP-driven intercalation of endotoxin does not require 
CD14 or any other membrane-associated protein. In living 
cells it may lead either to LPS neutralization or cell activation. 
CD14-independent activation has been described [4,14,15] and 
the data presented may provide the physico-chemical basis for 
this phenomenon. Thus, it is reasonable to assume that one 
prerequisite for the activation of host cells is the insertion of 
endotoxin molecules into their lipid matrix. This can be 
achieved in different ways, (1) via direct intercalation by hy- 
drophobic interaction of a-priori existing endotoxin mono- 
mers which are present in sufficient numbers at least for those 
chemotypes with longer sugar moieties, (2) via the intercala- 
tion of monomers or smaller endotoxin aggregates which are 
produced by the disaggregating properties of LBP, or (3) via 
the mediating role of mCD14. The mere intercalation of en- 
dotoxin molecules into the lipid matrix will not be sufficient 
for activation. We, therefore, propose a model postulating the 
existence of a transmembrane signal transducing protein 
which is triggered by binding of endotoxin molecules (Fig. 
6). The triggering signal requires, however, a particular con- 
formation of the lipid A moiety of the endotoxin molecule. 
Thus, only those endotoxins will activate which possess a lipid 
A part leading, in the isolated form, to nonlamellar aggregate 
structures. This implies that the conformation of the lipid A 
monomer is conical with the cross-section of the hydrocarbon 
moiety being larger than that of the polar backbone. In con- 
trast, a lipid A with a cylindrical conformation - leading to a 
lamellar aggregate structure - would not activate the signal 
transducer [30]. We furthermore postulate that for binding to 
the signalling protein, the existence of a sufficient number of 
hydroxy fatty acids in the endotoxin molecules is necessary 
allowing the formation of hydrogen bonds. This conforma- 
tional concept would readily explain the antagonistic action 
of biologically not active endotoxins. In these cases, the bind- 
ing sites of the transmembrane protein would be occupied by 
the inactive molecules, thus inhibiting the binding of the ac- 
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Fig. 5. Time kinetics of changes in donor emission intensity in RET 
experiments upon addition of 50 ktg/ml of rBPI23 (A) and rLBPs0 
(B) to 1 ml of 0.1 mM of double-labeled liposomes composed of 
the negatively charged phosphatidylserine (PS), the zwitterionic 
phosphatidylcholine (PC), and PLr4,~. 
tive structures. A candidate for the proposed transmembrane 
signal transducer could be an ion channel [31]. The result of 
the endotoxin interaction with the channel protein could lead 
to mismatches in intracellular ion concentrations provoking 
the activation of the succeeding signalling cascade. 
In our model, the abovementioned types of endotoxin inter- 
calation should express different efficiencies. Thus, the direct 
intercalation of monomers and the LBP-mediated process will 
lead to an intercalation somewhere in the lipid matrix, 
whereas the mCD14-mediated process will bind the endotoxin 
directly to the signalling protein assuming that mCD14 is 
located in the direct vicinity of the signal transducer. This 
assumption is backed by the observation that mCD14- 
mediated activation can be blocked by anti-CD14 antibodies. 
At high endotoxin concentration the blockade by anti-CD14 
antibodies can be overcome [14], and obviously in that case 
the CD14-independent activation pathway is initiated. One 
further point deserves attention. LBP, initially defined as li- 
popolysaccharide-binding protein, turns out not to be LPS- 
specific but rather to interact with and transport other nega- 
tively charged lipids. Thus, LBP seems to be a lipid transfer 
protein in a more general sense. This aspect will be subject o 
further investigations. 
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